BsUFA IV Is Coming: What’s Next for U.S. Biosimilars? Key Takeaways from FDA’s December 2025 BsUFA Reauthorization Meeting December 23, 2025 By Fabiola C. Gomez, Ph.D., CMC Regulatory Expert —

https://www.thefdalawblog.com/2025/12/bsufa-iv-is-coming-whats-next-for-u-s-biosimilars-key-takeaways-from-fdas-december-2025-bsufa-reauthorization-meeting/?utm_source=rss&utm_medium=rss&utm_campaign=bsufa-iv-is-coming-whats-next-for-u-s-biosimilars-key-takeaways-from-fdas-december-2025-bsufa-reauthorization-meeting